palmidrol has been researched along with Edema in 12 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", PEA co-ultramicronized with the natural antioxidant quercetin (PEA-Q), administered orally in two different rat models of inflammatory and OA pain, namely carrageenan paw oedema and sodium monoiodoacetate (MIA)-induced OA." | 7.85 | A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. ( Britti, D; Crupi, R; Cuzzocrea, S; Di Paola, R; Evangelista, M; Fusco, R; Gugliandolo, E; Impellizzeri, D; Morittu, VM; Schievano, C, 2017) |
| " The antiinflammatory activity of synthetic cannabinoid nabilone in the rat model of carrageenan-induced acute hindpaw inflammation was compared with that of the endocannabinoid palmitoylethanolamide and the nonsteroidal antiinflammatory drug indomethacin." | 7.71 | Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. ( Colleoni, M; Conti, S; Costa, B; Giagnoni, G; Parolaro, D, 2002) |
| ", PEA co-ultramicronized with the natural antioxidant quercetin (PEA-Q), administered orally in two different rat models of inflammatory and OA pain, namely carrageenan paw oedema and sodium monoiodoacetate (MIA)-induced OA." | 3.85 | A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. ( Britti, D; Crupi, R; Cuzzocrea, S; Di Paola, R; Evangelista, M; Fusco, R; Gugliandolo, E; Impellizzeri, D; Morittu, VM; Schievano, C, 2017) |
| " Intraplantar injection of CAR led to a time-dependent development of peripheral inflammation, in terms of paw edema, cytokine release in paw exudates, nitrotyrosine formation, inducible nitric oxide synthase and cyclooxygenase-2 expression." | 3.83 | A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation. ( Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R, 2016) |
| " The antiinflammatory activity of synthetic cannabinoid nabilone in the rat model of carrageenan-induced acute hindpaw inflammation was compared with that of the endocannabinoid palmitoylethanolamide and the nonsteroidal antiinflammatory drug indomethacin." | 3.71 | Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. ( Colleoni, M; Conti, S; Costa, B; Giagnoni, G; Parolaro, D, 2002) |
| " The lipidic nature and large particle size of PEA in the native state may limit its solubility and bioavailability when given orally, however." | 1.40 | Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. ( Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Siracusa, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ardizzone, A | 1 |
| Fusco, R | 2 |
| Casili, G | 1 |
| Lanza, M | 1 |
| Impellizzeri, D | 5 |
| Esposito, E | 5 |
| Cuzzocrea, S | 6 |
| Britti, D | 1 |
| Crupi, R | 4 |
| Gugliandolo, E | 2 |
| Schievano, C | 1 |
| Morittu, VM | 1 |
| Evangelista, M | 1 |
| Di Paola, R | 2 |
| Bartolucci, ML | 1 |
| Marini, I | 1 |
| Bortolotti, F | 1 |
| Bruschetta, G | 3 |
| Portelli, M | 1 |
| Militi, A | 1 |
| Oteri, G | 1 |
| Cordaro, M | 2 |
| Siracusa, R | 2 |
| Tronino, D | 1 |
| Offerta, A | 1 |
| Ostacolo, C | 1 |
| Russo, R | 3 |
| De Caro, C | 1 |
| Calignano, A | 3 |
| Puglia, C | 1 |
| Blasi, P | 1 |
| Lo Verme, J | 2 |
| Fu, J | 1 |
| Astarita, G | 1 |
| La Rana, G | 2 |
| Piomelli, D | 2 |
| Jonsson, KO | 1 |
| Persson, E | 1 |
| Fowler, CJ | 1 |
| D'Agostino, G | 1 |
| Sasso, O | 1 |
| Iacono, A | 1 |
| Raso, GM | 1 |
| Meli, R | 1 |
| Dalle Carbonare, M | 1 |
| Del Giudice, E | 1 |
| Stecca, A | 1 |
| Colavito, D | 1 |
| Fabris, M | 1 |
| D'Arrigo, A | 1 |
| Bernardini, D | 1 |
| Dam, M | 1 |
| Leon, A | 2 |
| Mazzari, S | 1 |
| Canella, R | 1 |
| Petrelli, L | 1 |
| Marcolongo, G | 1 |
| Conti, S | 1 |
| Costa, B | 1 |
| Colleoni, M | 1 |
| Parolaro, D | 1 |
| Giagnoni, G | 1 |
12 other studies available for palmidrol and Edema
| Article | Year |
|---|---|
Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Topics: Acetylcarnitine; Amides; Animals; Carrageenan; Cell Count; Cyclooxygenase 2; Disease Models, Animal; | 2021 |
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Carrageenan; Drug Combinations; Ede | 2017 |
Micronized palmitoylethanolamide reduces joint pain and glial cell activation.
Topics: Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Edema; Ethanolamin | 2018 |
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
Topics: Administration, Oral; Amides; Analgesics; Animals; Carrageenan; Chemistry, Pharmaceutical; Chromatog | 2014 |
Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo.
Topics: Adult; Amides; Analgesics; Animals; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Ca | 2016 |
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Amides; Animals; Carrageenan; Cell Line, Tumor | 2016 |
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Carrageenan; Crosses, Genet | 2005 |
The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
Topics: Amides; Animals; beta-N-Acetylhexosaminidases; Cannabinoids; Capillary Permeability; Edema; Endocann | 2006 |
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
Topics: Amides; Animals; Carrageenan; Central Nervous System; Drug Administration Routes; Edema; Endocannabi | 2007 |
A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story...
Topics: Amides; Animals; Anti-Inflammatory Agents; Benzoxazines; Body Temperature; Camphanes; Cannabinoid Re | 2008 |
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.
Topics: Amides; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell De | 1996 |
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
Topics: Acute Disease; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoid Rece | 2002 |